Lung Function and Patient-Reported Outcomes Response to Glycopyrrolate (SEEBRI™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Reversibility: Pooled Analysis of the GEM1 and GEM2 Studies

被引:0
|
作者
Bowling, A. [1 ]
Goodin, T. [1 ]
Price, B. [1 ]
Ozol-Godfrey, A. [1 ]
Sharma, S. [1 ]
Sanjar, S. [1 ]
Ohar, J. [2 ]
机构
[1] Sunov Pharmaceut Inc, Marlborough, MA USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2391
引用
收藏
页数:1
相关论文
共 35 条
  • [1] Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies
    Donald P. Tashkin
    Thomas Goodin
    Alyssa Bowling
    Barry Price
    Ayca Ozol-Godfrey
    Sanjay Sharma
    Shahin Sanjar
    Respiratory Research, 20
  • [2] Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies
    Tashkin, Donald P.
    Goodin, Thomas
    Bowling, Alyssa
    Price, Barry
    Ozol-Godfrey, Ayca
    Sharma, Sanjay
    Sanjar, Shahin
    RESPIRATORY RESEARCH, 2019, 20 (1):
  • [3] Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies
    Ohar, Jill A.
    Bowling, Alyssa
    Goodin, Thomas
    Price, Barry
    Ozol-Godfrey, Ayca
    Sharma, Sanjay
    Sanjar, Shahin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 461 - 470
  • [4] Lung Function and Patient-Reported Outcomes Response to Indacaterol/Glycopyrrolate (UTIBRON™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Reversibility: Pooled Analysis of the FLIGHT1 and FLIGHT2 Studies
    Sharma, S.
    Goodin, T.
    Bowling, A.
    Price, B.
    Ozol-Godfrey, A.
    Sanjar, S.
    Ohar, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] Effect Of Glycopyrrolate On Lung Function, Health Status And Dyspnea In Age Subgroups: A Pooled Analysis From The Gem1 And Gem2 Studies
    Mahler, D. A.
    Kerwin, E.
    Gifford, A. H.
    Yadao, A.
    D'Andrea, P.
    Uddin, A.
    Bray, B. Franke
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [6] Lung Function and Patient-Reported Outcomes Response to Indacaterol/Glycopyrrolate (UTIBRON™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Smoking Status: Pooled Analysis of the FLIGHT1 and FLIGHT2 Studies
    Sanjar, S.
    Goodin, T.
    Bowling, A.
    Price, B.
    Ozol-Godfrey, A.
    Sharma, S.
    Tashkin, D. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [7] Efficacy Of Inhaled Glycopyrrolate For Moderate-To-Severe COPD: A Subgroup Analysis By Gender From The Pooled Gem1 And Gem2 Studies
    Mahler, D. A.
    Satti, A.
    Spangenthal, S.
    Yadao, A.
    D'Andrea, P.
    Uddin, A.
    Franke-Bray, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [8] Glycopyrronium Demonstrates Significant Improvements in Lung Function in Patients With Moderate-to-Severe COPD: Pooled Analysis From the GEM1 and GEM2 Studies
    Kerwin, Edward
    Spangenthal, Selwyn
    Miller, S. David
    D'Andrea, Peter
    Henley, Michelle
    Eckert, Joerg H.
    Patalano, Francesco
    CHEST, 2015, 148 (04)
  • [9] Seebri™ Neohaler® (Glycopyrrolate) Versus Placebo in Patients with Moderate to Severe COPD: Analysis of Health-Related Quality of Life (HRQoL) from the GEM1 Study
    Feldman, G.
    Dembek, C.
    Rajagopalan, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [10] Seebri™ Neohaler® (Glycopyrrolate) Versus Placebo in Patients with Moderate to Severe COPD: Analysis of Health-Related Quality of Life (HRQoL) from the GEM2 Study
    Kerwin, E. M.
    Dembek, C.
    Rajagopalan, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197